In patients with the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI [MPS type VI]), dermatan sulfate may infiltrate the mitral and aortic valves and cause severe stenosis, insufficiency, or both. This report describes the clinical, echocardiographic, and pathological findings in four patients with Maroteaux-Lamy syndrome who had combined aortic and mitral valve disease. The clinical courses of these patients illustrate potential difficulties in preoperative assessment as well as the unique problems related to intraoperative and postoperative airway management.
Case Reports Case 1
A 30-year-old architect presented with a 24-month history of progressive but mild dyspnea precipitated by effort and cold weather (Table 1) . He appeared normal at birth, but by 18 months of age he was found, on the basis of excess mucopolysacchariduria, to have mucopolysaccharidosis (as did two of his eight siblings). His findings were considered most consistent with Morquio's syndrome (MPS type IV) because of "typical" radiologic features. At 5 years, he exhibited growth retardation and a systolic ejection murmur. Other medical problems included recurrent otitis media, mastoiditis, dental malocclusion, and corneal clouding. Subsequently, he underwent umbilical and right inguinal herniorrhaphies and re-repair of a right direct inguinal hernia.
At presentation (June 1989), his height was 132 cm (50th percentile for 9 years), and his weight was 40.7 kg (50th percentile for 12.5 years). He had coarse facial features with widely spaced teeth, macroglossia, and a flat nasal bridge with a prominent forehead. He had a grade 2/6 midsystolic murmur and a grade 2/6 holosystolic murmur at the apex with a very faint diastolic rumble. His ECG showed normal sinus rhythm at a rate of 70 beats per minute with right-axis deviation, and a chest radiograph showed an enlarged left atrium with pulmonary venous congestion. An echocardiogram 6 months earlier ( Figure 1 ) suggested stenosis of a bicuspid aortic valve, with a peak systolic gradient of 34 mm Hg and a mean gradient of 18 mm Hg; in addition, there was mild aortic valve regurgitation. The mitral valve leaflets were thick and stenotic with a mean gradient of 12 mm Hg. The mitral valve area, as measured by pressure half-time method, was 1.4 cm2 with mild mitral regurgitation. The tricuspid valve leaflets were also thickened but did not appear stenotic. The left ventricular ejection fraction was visually estimated to be 60%.
The Doppler examination was repeated in March 1989. The mean gradient across the mitral valve was 11 mm Hg. During this examination, the mitral valve area (by pressure half-time method) was 0.78 cm2. After the resting study, the patient exercised according to the Bruce protocol for 5.5 minutes. He reached a heart rate of 165 beats per minute, at which point the test was discontinued because of dyspnea. He was immediately placed into the left lateral decubitus position, and his mean gradient was remeasured at 18 mm Hg. While he was supine, pulmonary edema with rales and cyanosis developed; these responded to standing. From this study, it was clear that the patient's mitral stenosis was severe and that he had previously minimized his symptoms, which were quite significant. Repeat echocardiograms in June 1989 showed progression of mitral stenosis; mean gradient across the mitral valve was 27 mm Hg, and the calculated area was 0.68 cm2.
The The patient recovered well from surgery, was extubated on the fourth postoperative day, and was discharged from the hospital on the 12th day.
Early postoperative echocardiography showed an ejection fraction of 72%, with normal function of both prostheses. Cardiac tamponade developed and required echocardiography-directed pericardiocentesis; Doppler echocardiography 5 months after surgery showed a mean gradient across the aortic valve of 17 mm Hg and a mean gradient across the mitral prosthesis of 4 mm Hg. The patient returned to work and had no limitation in his activities. Fibroblast studies showed that he had a deficiency of the enzyme arylsulfatase B, a finding that confirmed the diagnosis of Maroteaux-Lamy syndrome (MPS type VI) rather than Morquio's syndrome. However, we recently learned that the patient died from respiratory complications after knee arthroscopy and hernia repair at another institution.
Case 2
A 34-year-old schoolteacher presented with an 18-month history of palpitations and exertional dyspnea. Her nocturnal dyspnea had been attributed to sleep apnea. She appeared normal as an infant, as did her younger brother (patient 1), but she had an umbilical hernia and splenomegaly. By age 2, she had signs of mucopolysaccharidosis, including growth retardation, pectus carinatum, bilateral hip dysplasia, and hepatomegaly.
During childhood, she had chronic otitis media that led to bilateral conductive hearing loss. She had an umbilical hernia repaired at age 26. Her eye findings became more prominent: exophthalmos, worsening photophobia, and diffuse corneal clouding with grayish granules typical of MPS types IV, V, and VI.
At age 28, a midsystolic murmur developed (grade 3/6) that was best heard over the left upper sternal border and radiated to the carotids and cardiac apex. right carpal tunnel syndrome. After administration of succinylcholine chloride, trismus developed, leading to great difficulty in endotracheal intubation.
Sleep studies suggested she had obstructive sleep apnea. Biochemical studies of cultured fibroblasts showed that she had a deficiency of the enzyme arylsulfatase B, confirming the diagnosis of Maroteaux-Lamy syndrome (MPS type VI). Before this time, she had been diagnosed mistakenly as having Morquio's syndrome (MPS type IV), as were her two siblings.
At presentation, she was 127 cm tall (50th percentile for 8.5 years) and weighed 33 kg (50th percentile for 10.5 years). Her facial features were coarse: prominent forehead, prominent eyes, large tongue, and widely spaced teeth. There was limitation in all joints, including the temporomandibular joint. There was a grade 3/6 midsystolic murmur at the base of the heart and a grade 3/6 holosystolic murmur with a 2/6 diastolic rumble over the apex. Her chest radiograph showed a prominent left atrium with pulmonary venous congestion. The ECG showed sinus rhythm with right-axis deviation and bifid P waves.
Echocardiography on April 4, 1990 (Figure 3 drome (type B MPS VI) described in previous reports, and their parents were normal.
Cardiac involvement in mucopolysaccharidosis is well established. Early reports from echocardiographic and autopsy studies emphasized that premature death in patients with this disorder was most often due to a combination of restrictive lung disease, respiratory infection, and heart disease.12-18 Krovetz and Schiebler'7 reported the cause of death in 87 patients with mucopolysaccharidosis: respiratory complications (n=31), cardiac causes (n=30), sudden death (n=10), and unknown (n=16). It is notable that two patients in that study died during induction of anesthesia.
Young and Harper's found that cardiac disease, present in 91% of their patients, was the most common cause of death in Hunter's syndrome (MPS type 11). Four of their patients had serious problems during attempted endotracheal intubation, and one died as a result of acute respiratory insufficiency.
The extent of cardiac involvement may be underestimated in patients with mucopolysaccharidosis because of restrictive pulmonary disease and skeletal abnormalities that limit the patients' activities. Johnson and associates'9 reported that echocardiography aided identification of the valvular deformity in five patients with the Hunter-Hurler phenotype who had no clinical evidence of mitral stenosis. In our patients, echocardiography was extremely helpful in identifying the valvular lesions and in following the progression of the hemodynamic disturbance.
There have been few reports of cardiac surgery in patients with mucopolysaccharidoses. Herd The typical anatomy of enlarged tongue, tonsils, adenoids, and mucous membranes and narrowed lower airway from glycosaminoglycan deposition predisposes these patients to respiratory complications and sleep apnea.26,27 Patient 2 had sleep apnea and lower airway obstruction beyond the reach of normal tracheostomy tubes. Herrick and Rhine28 reported an overall incidence of airway-related problems of 26% in 38 instances of general anesthesia administered to nine patients with MPS (types IH, II, III, and IV). Baines and Keneally8 described airway problems in eight of 16 patients with various mucopolysaccharidoses (MPS types IH, II, III, and VI). Both of their patients with Maroteaux-Lamy syndrome had multiple complications related to airway management, and one required elective tracheostomy for major surgery. The short neck, small and abnormal rib cage (due to scoliosis and thoracic hyperkyphosis), and decreased abdominal dimensions (due to lumbar hyperlordosis, gibbus formation, and hepatosplenomegaly) all contribute to a higher risk for anesthesia or sedation. Also, patients with MPS have frequent otolaryngeal infections, and recurrent bouts of pneumonia may develop in these patients. 29 Unfortunately, as our experience illustrates, patients with mucopolysaccharidosis often require several operations for correction of otolaryngeal and dental disorders, hernias, cataracts, and skeletal and cardiac defects.
Awake intubation was used successfully in our patients, and other groups have advocated similar control of the airway before anesthetic induction.28-30 Use of a fiberoptic bronchoscope for intubation has also been helpful. 31 Kempthorne and Brown32 suggested that difficulty of intubation correlated with increasing patient age, a finding that may result from chronic deposition of glycosaminoglycan in the mucous membranes and cartilage of the tracheobronchial tree.
Despite the potential airway problems, our experience and that of others indicate that cardiac valve replacement provides good palliation for this unique group of patients. Cure of the Maroteaux-Lamy syndrome requires replacement of the deficient enzyme, arylsulfatase B. This has been achieved recently by bone marrow transplantation in a 13-yearold girl, who exhibited promising early clinical and biochemical results, including decreased urinary excretion of mucopolysaccharides and ultrastructural absence of dermatan sulfate in bone marrow cells, peripheral blood lymphocytes, granulocytes, platelets, and hepatocytes.33 Twenty-four months after transplantation, hepatosplenomegaly was substantially decreased, and cardiopulmonary function was normal. Visual acuity and joint mobility also were improved.
The enzyme arylsulfatase B was purified by Gibson et al. 34 The active enzyme has a molecular mass of 57 kd, and complementary DNA, which codes for the 
